Sign inJoin waitlistJoin the waitlist

JC

Jonathan Coleman

H. Koch Chair · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

National Cancer Institute
2003–2004
New York Presbyterian Hospital
1998–2003
Cornell Univ Joan and Sanford I Weill Med Coll
1992–1996

Research

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Nature Medicine · 2017 · 2,750 citations
Epidemiology of Renal Cell Carcinoma
Review · European Urology · 2019 · 1,208 citations
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Genome biology · 2016 · 761 citations

PR
Paul Russo
92 papers
Ari Hakimi
78 papers · 16 as a resident
RM
Robert Motzer
39 papers
MV
Martin Voss
33 papers
KK
Kwanghee Kim
31 papers
GD
Guido Dalbagni
28 papers
BB
Bernard Bochner
27 papers
Renzo Di Natale
27 papers · 23 as a resident
Yingbei Chen
27 papers
MC
Maria Carlo
26 papers
KT
Karim Touijer
25 papers
RM
Roy Mano
25 papers

Clinical trials

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue
Principal investigator · Completed
Angiodynamics, Inc.
2022–2024
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Principal investigator · Withdrawn · Phase 3
Steba Biotech S.A.
2020–2030
Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2018–2025
Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.
Principal investigator · Completed · Phase 2
Steba Biotech S.A.
2017–2024